Research Goal. The Genealogist is being hired to research the following:
Research Goal. [description of unidentified ancestor]
Research Goal. It is the intent of this thesis to evaluate the association of maternal mortality with seat belt use and motor vehicle crashes in pregnant women. Former Director-General of the World Health Organization, Xxx Xxxx- wook, April 2005: Mothers, newborn and children represent the well- being of a society and its potential for the future. Their health needs cannot be left unmet without harming the whole of society (World Health Report, 2005).
Research Goal. The general goal of the COHERENO project is to map structures for successful collaboration between contractors and other supply actors that are involved in nearly zero-energy building (nZEB) single family home (SFH) renovations. To support this general goal, it is the goal of this work to detect most potential customer segments (of owner-occupants) for nZEB SFH renovations and to identify characteristics of customers (in this case innovators and early adopters) that are similar in ways relevant to business modelling (like for example for the definition of customer values).
Research Goal. The general goal of this thesis is to address the extent to which the forms of officially planned abandonment and neglect described above are indeed potentially harmful and represent a recipe for the collapse of war survivors who have to struggle to repair their own lives amidst shattered families and communities. In particular, this study explores the ways in which war survivors, amidst the extreme legacies of war and the post-war official neglect of these legacies, have been able to make use of locally available and accessible resources to develop strategies to engage in and to attain reconciliation and healing. Furthermore, the effectiveness of some of these strategies is studied.
Research Goal. The goal of the Parties’ research under this Agreement will be to generate data and results regarding the use of Codiak Licensed Know-How and of the Codiak Materials to (a) discover and research Exosome therapeutics that include Codiak Materials or Sarepta Materials and that are directed to the Research Targets and (b) generate data and results therefrom to help Sarepta assess whether to exercise a Sarepta Option hereunder, in each case, in accordance with the Research Plan.
Research Goal. The goal of this research was to develop a framework for flexible SLA template creation based on consumerís QoS requirements.
Research Goal. The objective of this study was to define the relationship between circulating heme and the heme degradation pathway in ACS pathogenesis and severity by establishing a measurable biomarker that is predictive of severe ACS risk with the future goal to improve prognosis. If successful, then we would have identified a biomarker to facilitate early intervention and management of severe ACS, and thereby reduce morbidity and mortality in SCD. We tested our hypothesis that “Unscavenged circulating heme increases the risk of severe ACS in children with SCD” using 2 interrelated specific aims: [1]: To determine the association between plasma levels of individual heme degradation biomarkers; total plasma heme (TPH), plasma free heme (PFH), plasma HO-1, plasma Hemopexin (Hx) during ACS and compare with their corresponding plasma levels at steady state. [2]: To determine the association between each individual heme degradation biomarkers [total plasma heme (TPH), plasma free heme (PFH), plasma HO-1, and plasma Hemopexin (Hx)] with severe ACS. Our overall strategy was to study SCD patients admitted to the hospital with ACS to define the relationship between circulating free heme, markers of heme degradation and severe ACS, using a cross sectional study design. Eligible patients with a confirmed diagnosis of SCD and ACS were recruited from the three hospitals of Children’s Healthcare of Atlanta: Xxxxxxxx, Scottish-Rite and Xxxxxx Spalding, which provides care for over 1,800 children and adolescents with SCD in the metro Atlanta area. According to the National Acute Chest Syndrome Study Group, the incidence of ACS in our patient population is approximately 20%. Eligible SCD patients admitted to the hospital with ACS or who develop ACS during admission were enrolled on study for a 3-year period (2015-2018) in the HOP-ACS Study. Patients were recruited within 48 hours of ACS diagnosis and informed consent or assent (where applicable) was obtained to the HOP- ACS protocol approved by the Emory Institutional Review Board (IRB) [IRB00047246]. ACS was defined as a new pulmonary infiltrate detected by chest radiograph (CXR) and associated with any of the following symptoms alone or in combination; pain (particularly chest/back), fever, hypoxia and /or difficulty breathing. SCD patients admitted to the hospital with ACS or who develop ACS during admission from December, 2015 to 2018, were identified based on the following criteria: Inclusion Criteria – A confirmed diagnosis of...
